1.
GAIN IN LIFE EXPECTANCY IN PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION TREATED EARLY WITH ENALAPRIL: A 23-YEAR FOLLOW-UP OF SOLVD COHORT IN BELGIUM
LONG-TERM EFFECT OF EARLY ENALAPRIL THERAPY ON CAUSES OF DEATH IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION: A 27-YEAR FOLLOW-UP OF SOLVD IN BELGIUM
Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients.
2.
3.
